RANI THERAPEUTICS HOLDINGS, INC.

Analyst Reco. Rani Therapeutics Holdings, Inc.

Equities

RANI

US7530181004

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-16 pm EDT			5-day change	1st Jan Change
6.87 ^USD	+19.27%		+71.75%	+106.93%

Mar. 27	Canaccord Genuity Adjusts Rani Therapeutics Price Target to $9 From $21, Maintains Buy Rating	MT
Mar. 25	HC Wainwright Adjusts Price Target on Rani Therapeutics to $12 From $16, Keeps Buy Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Canaccord Genuity Adjusts Rani Therapeutics Price Target to $9 From $21, Maintains Buy Rating	Mar. 27	MT
HC Wainwright Adjusts Price Target on Rani Therapeutics to $12 From $16, Keeps Buy Rating	Mar. 25	MT
Wedbush Cuts Rani Therapeutics Holdings' PT to $8 From $20, Keeps Outperform Rating	Nov. 10	MT
HC Wainwright Adjusts Price Target on Rani Therapeutics to $16 From $20, Maintains Buy Rating	Nov. 09	MT
HC Wainwright Adjusts Price Target on Rani Therapeutics to $20 From $22, Keeps Buy Rating	23-08-14	MT
Wedbush Lifts Rani Therapeutics Holdings' Price Target to $20 From $19, Keeps Outperform Rating	22-12-07	MT
UBS Initiates Coverage on Rani Therapeutics With Buy Rating, $15 Price Target	22-10-11	MT
Wedbush Adjusts Rani Therapeutics Holdings Price Target to $19 From $17, Maintains Outperform Rating	22-09-29	MT
Wedbush Adjusts Price Target on Rani Therapeutics Holdings to $17 From $28, Keeps Outperform Rating	22-08-12	MT
HC Wainwright Initiates Rani Therapeutics Holdings at Buy With $22 Price Target	22-07-27	MT
Wedbush Starts Rani Therapeutics Holdings at Outperform With $28 Price Target	22-06-13	MT
RANI THERAPEUTICS : Canaccord Genuity Starts Rani Therapeutics Holdings at Buy With $29 Price Target	21-08-25	MT
RANI THERAPEUTICS : BTIG Starts Rani Therapeutics Holdings at Buy With $24 Price Target	21-08-25	MT
RANI THERAPEUTICS : Cantor Fitzgerald Starts Rani Therapeutics Holdings at Overweight with $23 Price Target	21-08-24	MT
RANI THERAPEUTICS : Stifel Starts Rani Therapeutics Holdings at Buy with $24 Price Target	21-08-24	MT
RANI THERAPEUTICS : BofA Securities Starts Rani Therapeutics Holdings at Buy with $23 Price Target	21-08-24	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer